As of Feb 10
| -0.79 / -1.46%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 62.50, with a high estimate of 73.00 and a low estimate of 50.00. The median estimate represents a +17.30% increase from the last price of 53.28.
The current consensus among 5 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.